1 / 38

Medically Important Bacteria Gram Positive Cocci

Medically Important Bacteria Gram Positive Cocci. Phase I/ Module VII Dr Ekta Chourasia. Learning Objectives. At the end of the session, you should be able to: Enlist medically important GPCs Compare & contrast the features of staphylococci & streptococci

Download Presentation

Medically Important Bacteria Gram Positive Cocci

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medically Important BacteriaGram Positive Cocci Phase I/ Module VII Dr Ekta Chourasia

  2. Learning Objectives At the end of the session, you should be able to: • Enlist medically important GPCs • Compare & contrast the features of staphylococci & streptococci • List important virulence factors, toxins & enzymes, produced by them • Explain the role of virulence factors in the development of infection by GPCs • List pathogenicity of staphylococci & streptococci • Explain the basis of isolation & identification of GPCs in clinical specimens in laboratory. Learning resources: • Lecture & practical notes • Ananthanarayan Ch 22, 23, 24 Phase I/ Module VII Dr Ekta

  3. GPC Staphylococcus Streptococcus Enterococcus GNC Neisseria Moraxella Branhamella Medically Important Cocci Phase I/ Module VII Dr Ekta

  4. Gram Positive Cocci (GPC) Staphylococcus(GPCs in clusters) • Staphylococcus aureus • S. epidermidis • S. saprophyticus Streptococcus(GPCs in chains) • Streptococcus pyogenes (Group A ) • Streptococcus agalactiae (Group B) • Streptococcus pneumoniae (Pneumococcus) • Streptococcus viridans • Enterococcus (Group D) Phase I/ Module VII Dr Ekta

  5. In clusters (grapes like) or short chains Catalase + ve Facultative anaerobes Grows on ordinary medium Major components of normal flora – skin, nose & mucosa Produces localized infections Resistant to drying, Penicillin In chains or in pairs Catalase -ve Obligate & facultative anaerobes, grows in 5-10% CO2 Fastidious – requires enriched medium like BA Normal flora in throat, colon, female genital tract Infections tend to spread Delicate organism, sensitive to penicillin Staphylococci v/s Streptococci Phase I/ Module VII Dr Ekta

  6. Staphylococcus 1 Phase I/ Module VII Dr Ekta

  7. Clinically Important Species • Many species are medically important • S. aureus – Coagulase + ve • Most virulent species • Most common cause of bacterial infections, food poisoning & toxic shock syndrome • Coagulase –ve Staphylococci • S. epidermidis – important cause of prosthetic implant infections • S. saprophyticus – Urinary Tract Infection in young women Phase I/ Module VII Dr Ekta

  8. Staphylococcus aureus – General features • Coagulase positive • Beta hemolytic colonies on BA • Produces golden yellow pigment • Highly resistant bacteria • Can grow in the presence of 10 – 15% NaCl Phase I/ Module VII Dr Ekta

  9. Virulence Factors • Toxins – cytolytic & superantigen exotoxins • Enzymes & • Cell associated polymers and surface proteins Phase I/ Module VII Dr Ekta

  10. 1. Toxins • Haemolysins- Cytolytic, lyse RBCs of various animal species • Leucocidins - Kills leucocytes • Enterotoxin A to E - Food poisoning • Toxic shock syndrome toxin (TSST/ Enterotoxin F) – Toxic Shock Syndrome: rash, desquamation, multi organ failure • Epidermolytic ( Exfoliative ) toxin A & B – SSSS: Staphylococcal scalded skin syndrome (epidermal splitting & exfoliation) Phase I/ Module VII Dr Ekta

  11. 2. Extracellular enzymes • Catalase – enhance their survival in phagocytes by inactivating toxic H2O2 & free radicals released after the ingestion of staphylococci. • Coagulase - Clots plasma, responsible for ‘tube coagulase test’, confirmatory test for S.aureus • Hyaluronidase - Breaks down hyaluronic acid (connective tissue): initiation & spread of infection • Fibrinolysin (Staphylokinase) - Lyses fibrin clots: spread of infection • Nuclease - hydrolyses DNA • Lipase – Lipolytic: infection of skin & subcutaneous tissue Phase I/ Module VII Dr Ekta

  12. 3. Surface proteins • Protein A - Antiphagocytic • Clumping factor - bound coagulase, responsible for ‘slide coagulase test’, screening test for S.aureus Phase I/ Module VII Dr Ekta

  13. Pathogenicity (Staphylococcal diseases) Phase I/ Module VII Dr Ekta

  14. Pathogenicity of S. aureus • Cutaneous infections – • Folliculitis (boils), furuncle, burns and wounds • Deep infections – • Osteomyelitis, abscesses, pneumonia, endocarditis, septicemia • Toxin mediated infections – • Staphylococcal scalded skin syndrome (SSSS), • Toxic Shock Syndrome (TSS), • Food poisoning (in 1-8hr, vomiting ,diarrhea, nausea, self limited ) Phase I/ Module VII Dr Ekta

  15. Folliculitis Abscess Toxic shock syndrome SSSS Phase I/ Module VII Dr Ekta

  16. Lab diagnosis – S. aureus • Specimens: wound swab, pus, blood, feces • Microscopy: Gram stain - GPC in clusters • Culture • BA : beta hemolysis • NA : golden yellow pigment • Catalase positive • Coagulase positive Phase I/ Module VII Dr Ekta

  17. Coagulase Test Phase I/ Module VII Dr Ekta

  18. Staphylococcus epidermidis Major component of skin flora Nosocomial infections: device/ implant associated infections - shunts, catheters, artificial heart valves / joints, pacemaker BA: Non - hemolytic Identification Coagulase negative Prosthetic valve endocarditis Phase I/ Module VII Dr Ekta

  19. Drug Resistance in Staphylococci & MRSA • First developed resistance against Penicillin • Resistance to penicillin is mainly attributed to the production of enzyme, penicillinase (beta-lactamase) • To combat resistance due to penicillinase, Methicillin was developed & now methicillin resistant strains have evolved – MRSA Phase I/ Module VII Dr Ekta

  20. MRSA(Methicillin Resistant S. aureus) • Important cause of Nosocomial infections • post surgical wound infections • blood stream infections • ventilator associated pneumonia • Patients with open wounds, invasive devices and weakened immune systems are at greater risk for infection • Person to person spread – mainly from carriers (hospital staff, visitors), 25-30% carry in their nose. By contact with • colonized or infected patients • colonized or infected body sites of the personnel themselves, • devices, items, or environmental surfaces contaminated with body fluids containing MRSA. Phase I/ Module VII Dr Ekta

  21. MRSA(Methicillin Resistant S. aureus) • Difficult to treat • Prevention and infection-control strategies • Screening of staphylococcal carriers among hospital staff • Treatment of carriers with mupirocin, hexachlorophene • Proper sanitary procedures – surface sanitation, hand washing (alcohol gels), personal protective measures • Isolation of patients with open staphylococcal lesions * However carrier status prevents complete control • Treatment of MRSA infection - Glycopeptides • Vancomycin • teicoplanin Phase I/ Module VII Dr Ekta

  22. Streptococcus 1 Phase I/ Module VII Dr Ekta

  23. Classification Based on O2 Anaerobes Aerobes Peptostreptococci Growth on BA γhemolysis α hemolysis β hemolysis Incomplete hemolysis (green color) Complete hemolysis α / β / no hemolysis Lancefield groupingspecific C carbohydrate Ag on cell wall Enterococcus fecalis Strep. viridans Strep. pneumoniae Group A – U (21 groups) Griffith typing of Group A on MTR proteins into > 100 types Phase I/ Module VII Dr Ekta

  24. Beta hemolytic Group A Streptococcus(Streptococcus pyogenes) 1 Phase I/ Module VII Dr Ekta

  25. Streptococcus pyogenes – virulence factors Streptolysin O (SLO) Oxygen labile Damage cardiac cells Antigenic – produce ASLO Streptolysin S (SLS) Oxygen stable , non-antigenic Exotoxins Streptococcal Pyrogenic Exotoxin (SPEs) Manifestation of scarlet fever Exoenzymes Streptokinase (fibrinolysin) / Streptodornase (DNAase) / Hyalarunidase Phase I/ Module VII Dr Ekta

  26. Pathogenicity of Strep. pyogenes • Respiratory infections – • pharyngitis (sore throat), tonsillitis • otitis media, sinusitis • Skin & subcutaneous infections – • pyoderma, cellulitis • necrotising fasciitis (flesh eating bacteria) • Non suppurative complications – • Acute rheumatic fever – usually follows streptococcal pharyngitis • Acute glomerulonephritis – usually follows pyoderma Phase I/ Module VII Dr Ekta

  27. Lab diagnosis – Strep. pyogenes • Specimens: throat swab, pus, blood • Microscopy :Gram stain - GPC in chains • Culture: BA - beta hemolytic colonies • Identification tests - • Catalase Negative • Bacitracin sensitive • Penicillin sensitive • ASO titre / DNAase B test B B Phase I/ Module VII Dr Ekta

  28. Beta hemolytic Group B Streptococcus • Normal flora in lower GIT, female genital tract • Pathogenicity • Neonatal meningitis • Puerperal sepsis • Pneumonia 1 Phase I/ Module VII Dr Ekta

  29. Lab diagnosis – Group B Streptococci • Specimens: CSF, blood, vaginal smears, urine • Microscopy :Gram stain - GPC in chains • Culture: BA - beta hemolytic colonies • Identification tests • Catalase negative • Bacitracin resistance • CAMP Test + • Penicillin sensitive B P Phase I/ Module VII Dr Ekta

  30. Group D Streptococcus 1 Enterococcus – 2 imp. species E. fecalis E. faecium Normal flora in GIT, lower genital tract Nosocomial / opportunistic pathogen UTI, wound infection, endocarditis Resistance to cephalosporins, even vancomycin Phase I/ Module VII Dr Ekta

  31. Lab diagnosis - Enterococcus Specimens: urine, pus, blood Microscopy: Gram stain - GPC in pairs or short chains Culture: BA - alpha / beta / no hemolysis Identification tests - Catalase Negative Bile esculin positive Growth in 6.5% Nacl Penicillin resistance Phase I/ Module VII Dr Ekta

  32. Alpha hemolytic streptococciStreptococcus pneumoniae 1 Phase I/ Module VII Dr Ekta

  33. Features of Pneumococci • Virulence factor – capsule • Pathogenicity • Otitis media, sinusitis - commonest • Pneumonia • Meningitis • Other suppurative lesions - Pericarditis, conjunctivitis, arthritis, peritonitis • Vaccine available for prevention – polyvalent polysaccharide vaccine Phase I/ Module VII Dr Ekta

  34. Lab diagnosis • Specimen: CSF, blood, sputum, pus, swabs • Microscopy: Gram stain – GPC in pairs, capsulated, lanceolate shaped • Culture • BA/ CA – alpha hemolytic colonies • Identification tests • Catalase –ve • Optochin sensitive • Bile solubility Phase I/ Module VII Dr Ekta

  35. Alpha hemolytic streptococciStreptococcus viridans 1 • Normally present on teeth, throat, colon & female genital tract • Pathogenicity – • Endocarditis & Dental caries Phase I/ Module VII Dr Ekta

  36. Differences between Viridans Gp & Pneumococci Phase I/ Module VII Dr Ekta

  37. Phase I/ Module VII Dr Ekta

  38. Overview of the Medically Important Gram Positive Cocci Phase I/ Module VII Dr Ekta

More Related